News Archive
Remote Access
O365 Access DIAM VDI DIAM Remote Access TAC Remote Access (DMMI, DMAR, DMCN) DMTN VDI DMAT VDI DMTN Remote Access DMAT Remote Access DPAM Remote Access DSCN Remote Access

Quick Links

DENSO North America Website DENSO Presentation Library Oracle Fusion Oracle Fusion Help DENSO Benefits Healthy Horizons Empower Retirement DMTN Associate Resource Center
News Archive
Remote Access
O365 Access DIAM VDI DIAM Remote Access TAC Remote Access (DMMI, DMAR, DMCN) DMTN VDI DMAT VDI DMTN Remote Access DMAT Remote Access DPAM Remote Access DSCN Remote Access

Coronavirus

DENSO continues to monitor the risks of COVID-19 to our associates and operations


Key Documents & Links

  • US Face Mask Policy
  • COVID-19 Record System
  • NA Risk Minimization Toolkit
  • Travel & Visitor Guidelines
  • Business Ethics & Compliance Resources
  • CDC website

Who to Contact

Please contact us if you have any questions or concerns.

North America
COVID-19 Task Force
 
covid@na.denso.com

BCBSM Nurse Helpline
(for BCBSM members only)
tel: 1-800-775-2583  

Back

Share this:

April 19, 2021

DIAM COVID-19 Weekly Case Count & Vaccine Info (Apr. 9-16, 2021)

DENSO International America, Inc.
Weekly COVID-19 Case Update

DIAM Southfield has had seven (7) positive diagnoses in the past week. Michigan is seeing a surge in COVID-19 cases, so please continue to mask up and use all the recommended safety precautions.

  • Five (5) of the cases are associates who are working from home.
  • One associate was last on the DIAM Southfield campus on April 2 and started experiencing symptoms on April 9. They were last in Building 30, second floor; Building 3, first and second floors, and Building 4, first and second floors.
  • One associate was on the DIAM Southfield campus on April 11 and started experiencing symptoms on April 11. They were last in Building 30, second floor; Building 3, first and second floors, and Building 4, first and second floors.

All areas have been disinfected and anyone who came in contact with these associates has been notified.

For more information about DENSO’s safety protocols, view the Risk Minimization Toolkit (password: denso2020).

DENSO North America
Weekly COVID-19 Case Update

This week, 37 positive COVID-19 diagnoses were reported at DENSO affiliates in North America. This brings our total reported positive diagnoses to 3,007 across Canada, Mexico and the United States.

While we continue to see an overall case flattening, spread of COVID variants are triggering upward trends in some communities. Please continue to seek out vaccination opportunities when you are eligible, wear masks, social distance and avoid gatherings.

Country This Week’s Cases Total Positive Diagnosis Number of Deaths Exposed in Community Exposed at DENSO Unable to Determine Under Investigation
US 31 1713 4 1688 17 8 0
MX 5 1283 4 1208 48 27 0
CN 1 11 0 11 0 0 0
NA TOTALS 37 3007 8 2907 65 35 0

 

Exposed in Community – transmission attributed to community or home

Exposed at DENSO – transmission attributed to DENSO site contact

Unable to Determine – cannot confidently determine the source of exposure after thorough investigation (may have been exposed outside or inside of work)

Under Investigation – investigation is on-going both internally as well as with county health departments

Let’s Learn Together: Why is use of the one-shot (Johnson & Johnson/Jansen) vaccine on pause?

On Tuesday, April 13 the CDC and FDA issued a statement regarding the Johnson & Johnson COVID-19 vaccine. They are recommending a pause in the use of this vaccine out of an abundance of caution after the report of 6 cases (out of 6.8 million doses) of a rare kind of blood clot that appears to affect women of reproductive age. While the investigation is underway, most providers, including DENSO Family Health Centers, are stopping use of the J&J vaccine.

Over 189 million doses of COVID-19 vaccine were administered in the United States from December 14, 2020, through April 12, 2021 with reports of some mild side effects and extremely rare cases of severe reactions. The J&J vaccine is a different type of vaccine (viral vector) than the two-dose Pfizer and Moderna vaccines, which are an mRNA variety. Please get vaccinated as soon as you are eligible.

COVID-19 Vaccine: What You Can Do Once Fully Vaccinated

Two weeks after your final COVID vaccination, you are considered “fully vaccinated!” The Centers for Disease Control (CDC) has released a chart to describe some of the benefits of being vaccinated against COVID-19.

 

Published by DENSO INTERNATIONAL AMERICA, INC. for associates and friends of DENSO companies, joint ventures and affiliates in North America.

Follow Us

©DENSO INTERNATIONAL AMERICA, INC. 2023 All rights reserved. Ownership and Use

✖